Patrick Laurén

Dr. Patrick Laurén

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Journal of Controlled Release
Verified
Journal Article
Open access
MBMadhushree Bhattacharya
Madhushree Bhattacharya
MMMelina M. Malinen
Melina M. Malinen
PLPatrick Laurén
Patrick Laurén
Yan-Ru LouYan-Ru Lou
Yan-Ru Lou
SKSaara W. Kuisma
Saara W. Kuisma
MYMarjo Yliperttula
Marjo Yliperttula
Over the recent years, various materials have been introduced as potential 3D cell culture scaffolds. These include protein extracts, peptide amphiphiles, and synthetic polymers. Hydrogel scaffolds without human or animal borne components or added bioactive components are preferred from the immunological point of view. Here we demonstrate that native nanofibrillar cellulose (NFC) hydrogels derived from the abundant plant sources provide the desired functionalities. We show 1) rheological properties that allow formation of a 3D scaffold in-situ after facile injection, 2) cellular biocompatibility without added growth factors, 3) cellular polarization, and 4) differentiation of human hepatic cell lines HepaRG and HepG2. At high shear stress, the aqueous NFC has small viscosity that supports injectability, whereas at low shear stress conditions the material is converted to an elastic gel. Due to the inherent biocompatibility without any additives, we conclude that NFC generates a feasible and sustained microenvironment for 3D cell culture for potential applications, such as drug and chemical testing, tissue engineering, and cell therapy.

1 October 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
HPHeli Paukkonen
Heli Paukkonen
MKMikko Kunnari
Mikko Kunnari
PLPatrick Laurén
Patrick Laurén
THTiina Hakkarainen
Tiina Hakkarainen
VAVili-Veli Auvinen
Vili-Veli Auvinen
TLTimo J Laaksonen
Timo J Laaksonen

1 December 2014 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PLPatrick Laurén
Patrick Laurén
Yan-Ru LouYan-Ru Lou
Yan-Ru Lou
MRMari Raki
Mari Raki
AUArto Urtti
Arto Urtti
KBKim Bergström
Kim Bergström
MYMarjo Yliperttula
Marjo Yliperttula
Nanoscale celluloses have recently gained an increasing interest in modern medicine. In this study, we investigated the properties of plant derived nanofibrillar cellulose (NFC) as an injectable drug releasing hydrogel in vivo. We demonstrated a reliable and efficient method of technetium-99m-NFC labeling, which enables us to trace the in vivo localization of the hydrogel. The release and distribution of study compounds from the NFC hydrogel after subcutaneous injection in the pelvic region of BALB/c mice were examined with a multimodality imaging device SPECT/CT. The drug release profiles were simulated by 1-compartmental models of Phoenix® WinNonlin®. The NFC hydrogel remained intact at the injection site during the study. The study compounds are more concentrated at the injection site when administered with the NFC hydrogel compared with saline solutions. In addition, the NFC hydrogel reduced the elimination rate of a large compound, technetium-99m-labeled human serum albumin by 2 folds, but did not alter the release rate of a small compound (123)I-β-CIT (a cocaine analogue). In conclusion, the NFC hydrogels is easily prepared and readily injected, and it has potential use as a matrix for controlled release or local delivery of large compounds. The interactions between NFC and specific therapeutic compounds are possible and should be investigated further.

1 May 2013 in Acta Biomaterialia
Verified
Journal Article
Closed access
HJHelka Juvonen
Helka Juvonen
AMAnni Määttänen
Anni Määttänen
PLPatrick Laurén
Patrick Laurén
PIPetri Ihalainen
Petri Ihalainen
AUArto Urtti
Arto Urtti
JPJouko Peltonen
Jouko Peltonen

1 June 2020 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
VAVili-Veli Auvinen
Vili-Veli Auvinen
JVJuhani Virtanen
Juhani Virtanen
AMArto Merivaara
Arto Merivaara
VVValtteri Virtanen
Valtteri Virtanen
PLPatrick Laurén
Patrick Laurén
TLTimo J Laaksonen
Timo J Laaksonen

22 May 2018 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
PLPatrick Laurén
Patrick Laurén
HPHeli Paukkonen
Heli Paukkonen
TLTiina Lipiäinen
Tiina Lipiäinen
YDYujiao Dong
Yujiao Dong
TOTimo Oksanen
Timo Oksanen
TLTimo J Laaksonen
Timo J Laaksonen